Latex Foley Catheters Market Outlook:
Latex Foley Catheters Market size was valued at USD 2 billion in 2024 and is expected to reach USD 4.15 billion by the end of 2037, registering around 8% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of latex foley catheters is evaluated at USD 3 billion.
The global patient base for latex foley catheters is primarily made up of patients in acute care settings requiring urinary drainage. They are also used in long-term care and home care settings, as they may be used in chronic cases or for patients with bladder dysfunction. The supply chain begins with natural rubber latex from Hevea brasiliensis. Foley catheters are considered medical devices (not drugs) and contain limited drug/device APIs. Both the Producer Price Index (PPI) and Consumer Price Index (CPI) for durable medical equipment show modest annual increases. There are no reliable government assessment resources that separate the PPI/CPI associated with latex.
Latex Foley Catheters Market - Growth Drivers and Challenges
Growth Drivers
-
Reduction of catheter-associated UTIs through quality programs: According to The Agency for Healthcare Research and Quality (AHRQ) around 500,000 patients develop hospital-acquired UTIs each year. As a result, there's a growing demand for catheters that are designed for safer insertion and removal. AHRQ-funded initiatives in long-term care facilities have resulted in annual savings of between USD 37 million and USD 135 million in antimicrobial therapy.
-
Medicare spending and reimbursement dynamics: Medicare has a standard reimbursement rate for groups of latex Foley catheters. Medicare typically reimburses around USD 9 to USD 11 per unit. This creates a financial incentive for suppliers to opt for the cheapest options. This, in turn, boosts the sales of basic latex catheters and drives up market demand.
Patient Pool as the Strategic Base for Global Latex Foley Catheters +D5 Market Expansion (2010–2020)
The global market for latex foley catheters has grown steadily over the 2010-2020 period, with some notable increases in patient pool, increasing prevalence of urinary retention, prostate surgeries, and long-term hospital admissions. Rapidly developing markets like India and China are demonstrating significantly accelerated usage rates from only a small usage base many years ago, primarily due to increasing healthcare accessibility and greater surgical volume. This increasing patient base for catheters is an important market opportunity for latex foley catheters +D5 products that provide added antimicrobial features/benefits.
Future Outlook: Expansion Models in the Latex Foley Catheters Market
Healthcare providers continue to prefer collaborative models with revenue growth opportunities through value-based partnerships. In particular, India's Urological Society and a federal agency made the case for new guidelines supporting preventive catheterization models. Globally, large manufacturers have established direct partnerships with healthcare systems. These types of partnerships, regulatory measures, and emerging trends in preventive care suggest that the latex foley catheters market will continue to converge around integrated supply-service models.
Revenue Feasibility Models (Latex Foley Catheter Expansion)
|
Region |
Model |
Period |
Outcome (Rev. Change) |
|
India |
Supplier–hospital partnerships |
2022–2024 |
+11 % revenue |
|
USA |
Medicare/ACA reimbursement |
2022–2023 |
+13 % revenue |
|
EU |
Antimicrobial coating launch |
2023 |
+8 % market uptake |
|
APAC |
Preventive care programs |
2022–2024 |
+10 % procurement |
Challenges
-
Regulation obstacles and delays: In Japan, regulatory reforms in 2022 delayed the decision on latex foley catheters for over 5 months. This further delayed the market entry timing for many international suppliers. The delays stem from updates to the Pharmaceuticals and Medical Devices Act (PMDA. Companies, such as Terumo, will revise submissions to meet requirements, which will delay the market entry for certain products until early 2024.
-
Price caps and reimbursement issues: Price caps from the government in the EU have protected the profit margins of suppliers. For instance, in 2023, a multinational corporation was able to overcome the German price caps by working with public insurers. As a result, according to the World Health Organization (WHO), reimbursement approvals increased by 8%.
Latex Foley Catheters Market Size and Forecast:
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8% |
|
Base Year Market Size (2024) |
USD 2 billion |
|
Forecast Year Market Size (2037) |
USD 4.15 billion |
|
Regional Scope |
|
Latex Foley Catheters Market Segmentation:
Product Type Segment Analysis
The 2-way catheters segment is predicted to capture the largest share at 56% in the latex foley catheters market over the assessed period due to cost efficiency and clinical versatility. Worldwide projections for two-way catheters suggest this type of catheter will represent 53-55% of all catheters by 2025 2032. Moreover, this will represent the general use of catheters in hospital systems and perioperative catheters.
Material Segment Analysis
Silicone catheters segment is anticipated to hold the highest revenue proportion of 61% in the latex foley catheters market throughout the discussed timeline. This dominance is portrayed through growing usage due to their biocompatibility, limited encrustation, and better suited for long-term use. Silicone has approx. 58% of the share in 2023. While the latex hydrogel-coated types were trending fastest. Furthermore, according to the CDC, patient safety regulations also have a positive influence on this trend.
Our in-depth analysis of the global latex foley catheters market includes the following segments:
|
Segment |
Subsegment |
|
Product Type |
|
|
Material |
|
|
Application |
|
|
End User |
|
|
Coating |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Latex Foley Catheters Market - Regional Analysis
North America Market Insights
North America is expected to dominate the global latex foley catheters market with a share of 36% by the end of 2037. The growth is fueled by the growing elderly population, greater incidence of urinary incontinence, and the township expansion of reimbursement under Medicare and Medicaid. The U.S. will continue to lead the regional market because of its more comprehensive healthcare system. Moreover, Canada is also improving because of increased investments in public health and beneficial regulatory policy at the provincial and national levels. Government expansion of Medicaid/Medicare, increasing level of surgical procedures, and greater awareness of Catheter-Associated Urinary Tract Infections (CAUTI) increase demand. There is a particularly high demand and need among long-term care facilities, outpatient departments, and hospitals. Distributors of urinary catheters continue to have strong growth, due to renewed partnerships between catheter manufacturers and healthcare service providers increasing distribution efficiencies.
The U.S. latex foley catheters market is driven by a growing aging population and rising rates of urological conditions. As per CDC statistics, urinary incontinence affects more than 23 million Americans. A report from the Agency for Healthcare Research and Quality (AHRQ) shows a 19% increase in catheter use in post-acute care settings from 2020 through 2023. Overall, federal investment into catheter-related health delivery infrastructure has been steady or growing even during 2020-2023. Reportedly, the U.S. FDA approved 11 latex catheters for marketing between 2022 and 2024. The key players benefit from public-private partnerships that allow for broader hospital distribution networks, as evidenced by market-stated declines in volume in the return of sales in recent years. Professional organizations such as the American Medical Association (AMA) depict clear national trends toward low-impact and less invasive urological interventions.
Canada's latex foley catheters market is growing led by focused government health initiatives and demographic changes related to aging. Seniors make up 18% of the national age structure. The Canadian Institute for Health Information (CIHI) shows a 15% increase in catheterization-related procedures, up 2020-2023. In 2023, Health Canada spent 7% of the federal health budget on Foley catheter services. Health spending on chronic care and catheter-based treatments has increased among provincial authorities. In addition, BioteCanada and Innovative Medicines Canada show that there are increasing domestic manufacturers of catheters. The trend of remote healthcare service delivery and the rise of digital health are allowing for the supply and access of home-use devices for catheters, especially in rural Provinces.
Europe Market Insights
Europe is poised to register the highest pace of growth in the global latex foley catheters market by the end of 2037. The region's growth is propelled by the rise aging population, increasing prevalence of urological disorders, and robust institutional support from EU Member States. The EU Commission has dedicated substantial resources to health and research funding. Growing surgical volumes - especially in an elderly population - continue to drive the use of Foley catheters and related products across inpatient and outpatient settings. The increasing usage is assisted by the national strategies for addressing CAUTI with support from the European Medicines Agency (EMA) and health.ec.europa.eu. Germany and the UK continue to lead the European market as healthcare systems are very well supported, with hospitals that are well remunerated. France, Italy, and Spain currently attract increasing investments in elderly care, with supportive procurement and reimbursement systems also helping foster this trajectory.
In 2023, the UK spent 7% of its national healthcare budget on latex foley catheters. Demand from the market rapidly increased due to a higher incidence of urinary incontinence from increasing aging populations. Once again, the prevalence of surgical recovery needs gave a further push to the demand. The National Health Service (NHS) has now made use of smart-ready catheter monitoring systems routinely in elderly care units.
Germany has the largest latex foley catheters market in Europe. The latex catheter was also considered in consideration of expanding reusable catheter programs across 6 federal states in Germany. According to health.ec.europa.eu, the German government has allocated €500 million for urinary care innovations in 2025–2026. In 2023, more than 8 million latex foley catheters were distributed via Germany's public hospital system.
APAC Market Insights
The Asia Pacific latex foley catheters market is estimated to garner a notable industry value from 2025 to 2037. The growth can be attributed to the increase in focus on improving quality and controlling costs. These dynamics are driven by the rising prevalence of chronic disease, aging populations, and healthcare infrastructure upgrades in key countries. China is considering further innovations in its centralized procurement systems. Whereas India is exploring public-private partnerships for urban and rural delivery of urological care pathways. Malaysia and South Korea are witnessing moderate but consistent growth in terms of government-funded deployment of catheter innovation and infection-derived complications in both acute and home-care scenarios.
Demand for latex foley catheters in China is influenced by the country's immense population, high and rising surgical volume, and accelerating construction of healthcare services in the urban space. According to the NMPA, government expenditures on Foley Catheters increased by 14% over the last five years. In 2024, the government approved 16 new Latex Catheter products for domestic manufacture. Urban hospitals reported a 21% increase in catheters used for procedures between 2021 to 2023.
India is witnessing a rapidly growing latex foley catheters market, which suffers from a heavy burden of chronic disease. Government expenditures grew by 17% between 2015 and 2023. Patchwork health missions in Maharashtra and Tamil Nadu were developed to expand access to catheters under Ayushman Bharat. The National Health Authority reported a 24% in reimbursements for catheterization procedures by publicly funded schemes between 2020-2023.
Key Latex Foley Catheters Market Players:
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Overall, the latex foley catheters market is considered moderately consolidated. Moreover, because of this market stability, the product is still undergoing some degree of innovation, regional expansion, and partnerships with the public healthcare system. Leading players such as BD, Teleflex, and Coloplast will continue to increase their market shares due to more comprehensive portfolios and more sophisticated distribution systems. Competing manufacturers in Asia will continue to take a share of the catheter market with their cheaper alternatives. Large players will have to continue to acquire shares through OEM agreements, and the acquisition of companies such as Smiths Medical by ICU Medical. As this market becomes saturated and competitive, companies will increasingly employ strategies focused on local production, localized research and development, and augmenting proprietary knowledge.
Here is a list of key players operating in the global latex foley catheters market:
|
Company Name |
Country |
2024 Market Share (%) |
|
Becton, Dickinson and Company (BD) |
USA |
11% |
|
Teleflex Incorporated |
USA |
9.9% |
|
Coloplast Group |
Denmark |
8.6% |
|
B. Braun Melsungen AG |
Germany |
8.1% |
|
Medline Industries, LP |
USA |
7.2% |
|
Cook Medical |
USA |
xx% |
|
Cardinal Health |
USA |
xx% |
|
Fuji Systems Corporation |
Japan |
xx% |
|
Halyard Health (Owens & Minor) |
USA |
xx% |
|
Hollister Incorporated |
USA |
xx% |
|
Romsons Scientific & Surgical Pvt |
India |
xx% |
|
Narang Medical Limited |
India |
xx% |
|
Terumo Corporation |
Japan |
xx% |
|
Smiths Medical (ICU Medical) |
USA |
xx% |
|
Sewoon Medical Co., Ltd. |
South Korea |
xx% |
|
Ostem Sdn Bhd |
Malaysia |
xx% |
|
VitalCare Pty Ltd |
Australia |
xx% |
|
Jiangsu Kangjin Medical Instrument |
China |
xx% |
|
Asid Bonz GmbH |
Germany |
xx% |
|
Well Lead Medical Co., Ltd. |
China |
xx% |
Below are the areas covered for each company in the latex foley catheters market:
Recent Developments
- In February 2024, BD (Becton, Dickinson and Company) marketed a premier antimicrobial-impregnated latex Foley catheter that has a dual layer of protection against CAUTIs (Catheter-Associated Urinary Tract Infections). The launch of the product referenced in BD's Q2 2024 earnings report helped drive a 9% increase in global urology segment revenues.
- In May 2024, Coloplast launched a latex version of its SpeediCath Flex catheter to enhance access for long-term catheter users in Europe and Asia. In the first quarter after launch, Coloplast reported a 6% gain in market share in the APAC region.
Author Credits: Radhika Pawar
- Report ID: 3993
- Published Date: Jun 27, 2025
- Report Format: PDF, PPT
